Tourette Syndrome - Pipeline Insight, 2019 - ResearchAndMarkets.com

DUBLIN--()--The "Tourette Syndrome - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Tourette Syndrome - Pipeline Insight, 2019 offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Tourette Syndrome development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Scope of the Report

  • The report provides a snapshot of the pipeline development for the Tourette Syndrome
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Tourette Syndrome
  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Tourette Syndrome
  • The report also covers the dormant and discontinued pipeline projects related to Tourette Syndrome

Topics Covered

1. Report Introduction

2. Tourette Syndrome Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Tourette Syndrome

4. Comparative Analysis

5. Products in Clinical Stage

5.1 Drug Name : Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

6.1 Drug Name : Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

8.1 Drug Name : Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

Companies Featured

  • Neurocrine Biosciences Inc.
  • Psyadon Pharma
  • Synchroneuron Inc.
  • Abide Therapeutics
  • Neurocrine Biosciences
  • CatalystPharma
  • Edison Pharmaceuticals
  • Therapix Biosciences
  • Ipsen
  • Temple University

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/lg78v9/tourette_syndrome?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs